Alexander Yurek-George

Title: Alexander Yurek-George: Innovator in HDAC Inhibitors

Introduction

Alexander Yurek-George is a notable inventor based in Berkshire, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as HDAC inhibitors. His work is crucial in advancing therapeutic options for various diseases.

Latest Patents

Yurek-George holds a patent for FK 228 derivatives as HDAC inhibitors. This patent describes compounds that are FK228 analogues of the general formula (I) or (I'), isosteres thereof, and pharmaceutically acceptable salts thereof. These compounds are found to inhibit HDAC, wherein R, R, and R are the same or different and represent an amino acid side chain moiety, and each R is the same or different and represents hydrogen or C-Calkyl. This innovation has the potential to impact the treatment of conditions related to histone deacetylase activity.

Career Highlights

He is currently affiliated with the University of Southampton, where he continues to engage in research and development. His academic background and ongoing projects contribute to the advancement of knowledge in his field.

Collaborations

Yurek-George has collaborated with notable colleagues, including Arasu Ganesan and Graham Keith Packham. These partnerships enhance the research output and foster innovation in their shared areas of expertise.

Conclusion

Alexander Yurek-George is a prominent figure in the realm of HDAC inhibitors, with a patent that showcases his innovative approach to pharmaceutical development. His work at the University of Southampton and collaborations with esteemed colleagues further solidify his impact in the field.